• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Active Biotech AB - Product Image

Active Biotech AB

  • Published: April 2014
  • Region: Global
  • 41 Pages
  • Wright Investors Service

A textual analysis of the financial results for Active Biotech AB compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Active Biotech AB. There is a textual review of the financial results of Active Biotech AB versus Allenex AB, Medivir AB and Bioinvent International AB. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company READ MORE >

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Cyprotex PLC, Biotie Therapies and Jerini AG

Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Biotie Therapies - Product Thumbnail Image

    Biotie Therapies

    • Published: March 2014
    • Region: Global
  • Jerini AG - Product Thumbnail Image

    Jerini AG

    • Published: March 2014
    • Region: Global
  • Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics - Product Thumbnail Image Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics

    Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics

    • Language: English
    • 1064 Pages
    • Published: July 2013
    • Region: Global
    FROM
  • Topotarget A/S - Product Thumbnail Image

    Topotarget A/S

    • Language: English
    • 42 Pages
    • Published: March 2014
    • Region: Global
  • Bioinvent International AB - Product Thumbnail Image

    Bioinvent International AB

    • Language: English
    • 41 Pages
    • Published: March 2014
    • Region: Global
  • Karo Bio AB - Product Thumbnail Image

    Karo Bio AB

    • Language: English
    • 41 Pages
    • Published: March 2014
    • Region: Global
  • Medivir AB - Product Thumbnail Image

    Medivir AB

    • Language: English
    • 41 Pages
    • Published: March 2014
    • Region: Global
  • IDL Biotech AB - Product Thumbnail Image

    IDL Biotech AB

    • Language: English
    • 42 Pages
    • Published: April 2014
    • Region: Global
  • Allenex AB - Product Thumbnail Image

    Allenex AB

    • Language: English
    • 42 Pages
    • Published: March 2014
    • Region: Global
  • Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image
    FROM